|
Dopamine D1 Receptor in Cancer
|
11 November 2020 |
|
Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer
|
06 November 2020 |
|
Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy
|
04 November 2020 |
|
Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia Treatment
|
30 October 2020 |
|
Solubility measurement, solubility behavior analysis and thermodynamic modelling of melatonin in twelve pure solvents from 278.15 K to 323.15 K
|
30 October 2020 |
|
Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
|
28 October 2020 |
|
Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling
|
27 October 2020 |
|
Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial
|
27 October 2020 |
|
Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives
|
23 October 2020 |
|
Melatonin Increases the Anticancer Potential of Doxorubicin in Caco-2 Colorectal Cancer Cells
|
23 October 2020 |